Alyeska Investment Group
NEUE

Alyeska Investment Group’s NeueHealth NEUE Stock Holding History

Alyeska Investment Group’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,500
Closed -$10.3M – 813
2021
Q2 		$10.3M Buy
+7,500
New +$10.3M 0.12% 203

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DIC
Deer IX & Co Larchmont, New York $971M AUM 24.77% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Alyeska Investment Group's NEUE Position: Q3 2021 in Review

Alyeska Investment Group sold out of NeueHealth (NEUE) in Q3 2021, closing a stake of 7,500 shares — an estimated $10.3M sold.

Alyeska Investment Group first reported a position in NEUE in Q2 2021 and held it in 1 quarter. The position peaked at $10.3M in Q2 2021. 102 funds tracked by Wall St. Rank hold NEUE as of Q3 2021.

  • Alyeska Investment Group reported no remaining NeueHealth position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 7,500 NeueHealth shares in Q3 2021, an estimated $10.3M.
  • Alyeska Investment Group first reported a position in NeueHealth in Q2 2021 and held it in 1 quarter.
  • Alyeska Investment Group's NeueHealth position peaked at $10.3M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held NeueHealth as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.